Icon

CYMBALTA (nda021427)- (EQ 20MG BASE,EQ 30MG BASE,EQ 60MG BASE)

DULOXETINE HYDROCHLORIDE LILLY
EQ 20MG BASE,EQ 30MG BASE,EQ 60MG BASE
Yes No
2020-Mar-10 Expired
None None
None No
CYMBALTA® is a serotonin and norepinephrine reuptake inhibitor (SNRI) indicated for the treatment of the following conditions: • Major depressive disorder (MDD) in adults • Generalized anxiety disorder (GAD) in adults and pediatric patients 7 years of age and older • Diabetic peripheral neuropathic pain (DPNP) in adults • Fibromyalgia (FM) in adults and pediatric patients 13 years of age and older • Chronic musculoskeletal pain in adults.
21 3 18
Total Other Developers 28
Drugs with Suitability Yes
EQ 20MG BASE ** ** - 11 -
EQ 30MG BASE ** ** Up - 10
EQ 60MG BASE ** ** Up - 11
NDA Sales Available Total Generic Sales Available
Yes 13
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ***** *** ***** ******* *********** **** **. **-*, ***** *-*, ***** ********** ****, *****, ********, *** ******, ***** (***) ***
****** ******** ****** ******** ****** ******* *********** **** ** *-** & *-**, ***** ********** ******,, *****, *** ******, ***** (***) ***
****** ***** ****** ***** ************ ******* *********** ****** **. ***, *** & ***, ******* ***** ******** ******* ** * *, *******-*******, ***-******, ****. - *********, *********, ******* ******, ***** (***) ***
****** ***** ******** ***** ************ ******* *********** ****** **. ***, *** & ***, ******* ***** ******** ******* ** * *, *******-*******, ***-******, ****. - *********, *********, ******* ******, ***** (***) ***
****** *** ***** *** ************** ********** ******* *********** *****-****** *******, *****, ******* ******, ***** (***) ***
****** ******* ******* *************** ******* *********** *********-******* *******, ******, ******-****, ****. *******, ******, ******* ******, ***** (***) ***
****** ********* ****** *** ********* ****** ******* *********** ****-***, **. **.*** & ***, **********, ********** ******, *******-********** ********, *******, ********* ******, ***** (***) ***
****** ********* ****** *** ******** ****** ******* ******* *** *********** ****-**, **.**'*.**,**,**,**,** ** **,***&***, ************** * & **.** *,*,****,**,**,**,**&**, ************ *, *********** ******, **********, ****** ******* ******, ***** (***) ***
****** ******** ******** ********** ******* *********** **-**/*-***/*, ********** ********* ************* (****),, *****, *********** ******, ***** (***) ***
****** ******* ******* *************** ******* *********** *********** ********, ******* *******, *.*. *******, **** *****, ****** *****,, **********, ******* ******, ***** (***) ***
****** ************ **** ************** ******, *.*. *********** ***** ** **** *****, **-**, ***********, *****, ***** (***) ***
****** ***** **** *** ***** ************ ******* *********** **** **. ***, ******* ****** ***** *****, *******, ******, *****, ***** & *** ******, ***** (***) ***
****** ****** **** *** *** ****** **** ******* *********** **** ***, **** **. **-***, ****-**, ***, **********, *********, ********* ******, ***** (***) ***
****** ******** ****** *** ******** *************** ******* *********** ******* *****, **** ****** **********,****** *****, ******** *****, ******** ******* ******, ***** (***) ***
****** ******** *** ******** ****** ************** **., ***. *********** ******* ****, ******, ******** ******, ***** (***) ***
****** ****** ****** *** ****** ****** ******* *********** **** **. *-*** /* ***** *** - **** **, *******, ******* ******, ***** (***) ***
****** ****** ****** *** ****** ****** ******* *********** *-*\*\*, **** ****, *******, *********** *************, *********** ******, ***** (***) ***
****** ******* ****** ***** *** *********, ***. *** *********** **.**, **. ***, ***** *. **., ***** ****., ******* ****, *****, ****** (***) ***
****** ******* ****** ***** ******* ****** ************** **.,***. *********** **. ** ***** ****, **** ********, *******, ******** ******, ***** (***) ***
****** ***** *** *** ********** ** **, *** *** ******* **** *********** *** ******* ******* *****, *******, ******** (**) *****, ****** ****** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.